Kristie L. Kahl is vice president of content at MJH Life Sciences, overseeing CURE®, CancerNetwork®, the journal ONCOLOGY, Targeted Oncology, and Urology Times®. She has been with the company since November 2017.
She is a graduate of Rider University, where she acquired a Bachelors of Art in journalism, as well as a graduate of Temple University, where she received her Masters of Science in Sports Management.
Follow Kristie on Twitter at @KristieLKahl, or email her at kkahl@mjhlifesciences.com.
Guidelines Equip Patients to Understand Immunotherapy Side Effects
February 20th 2018To help educate patients and enable health care teams to effectively manage these side effects, the National Comprehensive Cancer Network (NCCN) and the American Society of Clinical Oncology (ASCO) issued new guidelines on understanding and managing immunotherapy-related toxicities.
Myeloma Precursor May Cause Disease Progression, Even 30 Years Later
February 19th 2018An abnormal protein found in the blood – called monoclonal gammopathy of undetermined significance (MGUS) – may lead to multiple myeloma progression, even after 30 years of disease stability, according to study results published in the New England Journal of Medicine.
Hidden Burdens and Trying to Feel Normal: The Effects of an Ovarian Cancer Diagnosis
February 18th 2018After a cancer diagnosis and treatment, one may question when they will actually start to feel “normal” again, whatever that may be. The Ovarian Cancer Prognosis and Lifestyle (OPAL) study set out to help women with ovarian cancer to understand just that.
Physical Therapy Helps Women Recover Arm Mobility After Lymph Node Surgery
February 13th 2018“Our take home message here is that all women receiving lymph node dissection, whether it is axillary or sentinel, should receive physical therapy to regain range of motion more quickly after surgery, and thus, help maintain physical functioning,” said Electra D. Paskett, Ph.D., MO.
Survey Reveals Impairment in Sexual Function Among Germ-Cell Tumor Survivors
February 9th 2018Germ cell tumors are growths that form from reproductive cells, which can be malignant or benign. In men, these tumors typically form in the testicles. The plus side is these tumors tend to respond well to treatment, even when diagnosed at later stages. However, one problem still persists after a cure.
Visible Melanoma Lesions Affect Patients' Physical, Emotional Quality of Life
February 8th 2018A recent study highlighted the additional psychological effects that patients with locally advanced cutaneous melanoma go through, particularly because their lesions are a visible part of their everyday life.
Viruses May Be the Future of Boosting Immunotherapy in Brain Cancer
February 7th 2018In recent years, major advances have been made in the immunotherapy scape, as it has become instrumental in revolutionizing the way oncologists treat a variety of cancers. However, its success in patients with brain cancer has been extremely limited.
LivingWith App Helps Patients Navigate 'New Normal' After Cancer Diagnosis
February 7th 2018“Regardless of their prognosis, they want to live, and they want to live their normal life. They don’t want it to be what defines them and live their life to the fullest. So, that is where technology can really be helpful," said Savitiri Basavaiah, of Pfizer Oncology.
Screening Beyond Those With Cancer History May Be More Effective
February 6th 2018As genetic testing becomes more accessible with advanced technology and decreased costs, population-based testing for breast and ovarian cancer may be more cost effective in the long run, according to study results published in Journal of the National Cancer Institute.
Super Bowl Challenge Starts Off the Field With Lung Cancer Awareness
February 5th 2018As the Philadelphia Eagles and New England Patriots fight for claim over the Super Bowl trophy tonight, two lung cancer survivor advocates are in Minneapolis fighting for another reason: to raise research and awareness dollars.
MSI Status Shows No Effect on Metastatic Colorectal Cancer Prognosis
February 3rd 2018Microsatellite instability (MSI) status appeared to have no association with outcomes in patients with liver metastases that spread from colorectal cancer (CRC), according to results from an international, multi-institutional analysis presented at the 2018 Gastrointestinal Cancers Symposium.